— Know what they know.
Not Investment Advice
Also trades as: FFVWF (OTC) · $vol 0M · FFNT.CN (CNQ) · $vol 0M

FFNTF OTC

4Front Ventures Corp.
1W: +900.0% 1M: +0.0% 3M: +900.0% YTD: +900.0% 1Y: -90.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $12460 mcap · 484M float · 0.013% daily turnover · Short 53% of daily vol

Cash Flow Trends

Operating Cash Flow
-$2M -120.9% ▼
Capital Expenditures
$3M -38.1% ▼
5Y CAGR: +111.7%
Free Cash Flow
-$5M -182.0% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$11M -47.1% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$181M-$47M-$38M-$47M-$46M
Depreciation & Amort.$5M$9M$7M$8M$6M
Stock-Based Comp.$6M$5M$10M$7M$7M
Change in Working Capital$548K$6M$8M$22M$9M
Other Non-Cash Items$145M$8M$18M$23M$16M
Operating Cash Flow-$25M-$14M$6M$9M-$2M
— Investing Activities —
Capital Expenditures-$23M-$14M-$14M-$2M-$3M
Acquisitions (Net)$6M$61M$1M-$25K$0
Investment Purchases-$400K$0-$481K$0$0
Investment Sales$0$0-$602K$0$0
Other Investing-$2M-$7M$858K-$24M-$83K
Investing Cash Flow-$19M$39M-$13M-$27M-$3M
— Financing Activities —
Net Debt Issuance$54M-$33M$9M$11M-$5M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$5M$4M-$1M$3K-$640K
Financing Cash Flow$49M-$15M$11M$11M-$6M
Net Change in Cash$4M$11M$4M-$7M-$11M
Cash End of Period$6M$19M$23M$15M$3M
Free Cash Flow-$48M-$28M-$8M$6M-$5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms